| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |